5.780USD-4.39%Mkt Cap: 1.42B USDP/E: —Last update: 2026-06-01
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treat…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.42B USD
Enterprise Value1.49B USD
Revenue (TTM)427.68M USD
Gross Profit367.78M USD
Net Income (TTM)-61.60M USD
Revenue/Share1.761 USD
Last Price5.780 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees489
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)11.73
PEG—
EV/EBITDA-43.70
EV/Revenue3.48
P/S3.49
P/B10.03
EPS (TTM)-0.24
EPS (Forward)0.52
52W Range
3.49047% of range8.400
52W High8.400 USD
52W Low3.490 USD
Profitability
Gross Margin90.29%
Oper. Margin-34.71%
EBITDA Margin-7.96%
Profit Margin-15.12%
ROE-36.90%
ROA-12.28%
Growth
Revenue Growth27.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-42.48M USD
CapEx (TTM)1.49M USD
FCF Margin0.02%
FCF Yield0.01%
Net Debt-3.95M USD
Net Debt/EBITDA0.12
Balance Sheet
Debt/Equity1.25
Current Ratio3.48
Quick Ratio2.93
Book Value/Sh0.6020 USD
Cash/Share0.9640 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)16.33 USD
Target Range13.00 USD – 19.00 USD
# Analysts9
Ownership
Shares Out.247.03M
Float221.19M
Insiders3.19%
Institutions70.64%
Short Interest
Short Ratio5.6d
Short % Float9.87%
Short % Out.9.66%
Shares Short23.86M
Short (prev mo.)24.02M
Technical
SMA 506.160 (-6.2%)
SMA 2006.144 (-5.9%)
Beta0.61
S&P 52W Chg27.94%
Avg Vol (30d)3.69M
Avg Vol (10d)2.58M
Technical Indicators
RSI (14)43.3
MACD-0.0472
MACD Signal0.0041
MACD Hist.-0.0513
BB Upper7.293 USD
BB Middle6.508 USD
BB Lower5.724 USD
BB Width24.11%
ATR (14)0.2984 USD
Vol Ratio (20d)0.37x